1. Home
  2. INDI vs ASMB Comparison

INDI vs ASMB Comparison

Compare INDI & ASMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo indie Semiconductor Inc.

INDI

indie Semiconductor Inc.

HOLD

Current Price

$4.41

Market Cap

688.9M

Sector

Technology

ML Signal

HOLD

Logo Assembly Biosciences Inc.

ASMB

Assembly Biosciences Inc.

HOLD

Current Price

$35.87

Market Cap

553.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
INDI
ASMB
Founded
2007
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
688.9M
553.6M
IPO Year
N/A
2010

Fundamental Metrics

Financial Performance
Metric
INDI
ASMB
Price
$4.41
$35.87
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
6
Target Price
$6.25
$43.40
AVG Volume (30 Days)
3.4M
134.1K
Earning Date
11-06-2025
11-10-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$217,396,000.00
$37,191,000.00
Revenue This Year
$1.91
$42.01
Revenue Next Year
$30.15
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
31.30
52 Week Low
$1.53
$7.75
52 Week High
$6.05
$39.71

Technical Indicators

Market Signals
Indicator
INDI
ASMB
Relative Strength Index (RSI) 55.32 57.21
Support Level $3.44 $34.42
Resistance Level $4.76 $38.82
Average True Range (ATR) 0.27 2.11
MACD 0.14 -0.41
Stochastic Oscillator 78.26 40.31

Price Performance

Historical Comparison
INDI
ASMB

About INDI indie Semiconductor Inc.

Indie Semiconductor Inc is empowering the Autotech revolution with next-generation automotive semiconductors and software platforms. It focuses on edge sensors for Driver Assistance Systems including LiDAR, connected car, user experience, and electrification applications. These technologies represent the core underpinnings of both electric and autonomous vehicles, while the user interfaces transform the in-cabin experience to mirror and seamlessly connect to the mobile platforms. Geographically, the company generates majority of its revenue from Greater China and rest from United States, Europe, South Korea and other regions.

About ASMB Assembly Biosciences Inc.

Assembly Biosciences Inc is a clinical-stage biotechnology company. It is advancing two platform programs, a novel class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and novel class of oral synthetic live biotherapeutics, which are designed to restore health to a dysbiotic microbiome. The company's HBV-cure program is aimed at increasing the current low cure rate for patients with HBV and is pursuing multiple drug candidates that inhibit multiple steps of the HBV lifecycle. Assembly has discovered several novel core protein Allosteric Modulators, which are small molecules that directly target and allosterically modulate the HBV core protein. The majority of the revenue is generated from the HBV cure program.

Share on Social Networks: